| Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma M Kamal, AM Shaaban, L Zhang, C Walker, S Gray, N Thakker, C Toomes, ... Breast cancer research and treatment 121, 555-563, 2010 | 89 | 2010 |
| The effect of soluble E-selectin on tumor progression and metastasis SA Kang, CA Blache, S Bajana, N Hasan, M Kamal, Y Morita, V Gupta, ... BMC cancer 16, 1-13, 2016 | 60 | 2016 |
| Patient-derived Mammosphere and Xenograft Tumour Initiation Correlates with Progression to Metastasis REDGAKSMKFLSBMSASGASCMBMAZSSCCKAGACAAMWCSOBGFSJHRB Clarke J Mammary Gland Biol Neoplasia, 2016 | 48 | 2016 |
| Prognosis for splicing factor PRPF8 retinitis pigmentosa, novel mutations and correlation between human and yeast phenotypes KV Towns, A Kipioti, V Long, M McKibbin, C Maubaret, V Vaclavik, ... Human mutation 31 (5), E1361-E1376, 2010 | 44 | 2010 |
| Microcephalin is a new novel prognostic indicator in breast cancer associated with BRCA1 inactivation J Richardson, AM Shaaban, M Kamal, R Alisary, C Walker, IO Ellis, ... Breast cancer research and treatment 127, 639-648, 2011 | 41 | 2011 |
| E-selectin Targeting PEGylated-thioaptamer Prevents Breast Cancer Metastases. TT Morita Y, Kamal M, Kang SA, Zhang R, Lokesh GL, Thiviyanathan V, Hasan N ... Mol Ther Nucleic Acids 5 (12), 2016 | 31 | 2016 |
| Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion M Kamal, DL Holliday, EE Morrison, V Speirs, C Toomes, SM Bell Oncology Reports 38 (1), 283-292, 2017 | 23 | 2017 |
| Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in cancer stem cells F Ashour, MH Awwad, HEL Sharawy, M Kamal Journal of the Egyptian National Cancer Institute 30 (2), 45-48, 2018 | 16 | 2018 |
| PIC&RUN: An integrated assay for the detection and retrieval of single viable circulating tumor cells M Kamal, S Saremi, R Klotz, O Iriondo, Y Amzaleg, Y Chairez, V Tulpule, ... Scientific reports 9 (1), 17470, 2019 | 14 | 2019 |
| Circulating tumor cells accurately predicting progressive disease after treatment in a patient with non-small cell lung cancer showing response on scans CE Horton, M Kamal, M Leslie, R Zhang, T Tanaka, M Razaq Anticancer research 38 (2), 1073-1076, 2018 | 10 | 2018 |
| Circulating Tumor Cells in Breast Cancer: A Potential Liquid Biopsy M Kamal, W Razaq, M Leslie, S Adhikari, T and Tanaka Breast Cancer - From Biology to Medicine, 119-145, 2017 | 8 | 2017 |
| N-Acetyl-L-cysteine Promotes Ex Vivo Growth and Expansion of Single Circulating Tumor Cells by Mitigating Cellular Stress Responses T Teng, M Kamal, O Iriondo, Y Amzaleg, C Luo, A Thomas, G Lee, CJ Hsu, ... Molecular Cancer Research 19 (3), 441-450, 2021 | 7 | 2021 |
| Cytopathologic identification of circulating tumor cells (CTCs) in breast cancer: Application of size-based enrichment 2* Mohamed Kamal1, Macall Leslie1, Crista Horton3, Natalie Hills3, Rachel ... Clinical and diagnostic pathology, 2019 | 5 | 2019 |
| Reduced MCPH1 expression in breast cancer and response to chemotherapy J Richardson, A Shaaban, M Kamal, I Ellis, V Speirs, A Green, SM Bell Breast Cancer Research 12 (Suppl 1), P41, 2010 | 2 | 2010 |
| Ethnicity influences breast cancer stem cells' drug resistance M Kamal, EHO Nafie, S Elsers, S Alanwar, R Ibrahim, F Farag, M Mlees, ... Breast J 24, 701-703, 2018 | 1 | 2018 |
| Loss of CSMD1 disrupts mammary epithelial morphogenesis M Kamal, AM Shaaban, DL Holliday, C Toomes, V Speirs, SM Bell Breast Cancer Research 12, 1-2, 2010 | 1 | 2010 |
| An Image-Based Identification of Aggressive Breast Cancer Circulating Tumor Cell Subtypes M Kamal, YJ Wang, S Plummer, A Dickerson, M Yu Cancers 15 (10), 2669, 2023 | | 2023 |
| An assay for the detection and isolation of single live circulating tumor cells using Accucyte/Rarecyte platform M Kamal, S Saremi, RV Klotz, O Iriondo, M Yu Cancer Research 79 (13_Supplement), 1336-1336, 2019 | | 2019 |
| Role of Cancer stem cells in drug resistance of ER+ breast Cancer F Ashour, M Kamal Journal of Molecular Cancer 1 (2), 2018 | | 2018 |
| Role of circulating tumor cells by rare cell enumeration system in predicting response of non-small cell lung cancers to therapy. M Malla, R Bernardo, C Horton, M Kamal, L Macall, T Tanaka, MA Razaq Journal of Clinical Oncology 36 (15_suppl), e24058-e24058, 2018 | | 2018 |
Valerie SpeirsProfessor of Molecular Oncology, Aberdeen UniversityVerified email at abdn.ac.uk
